Bio-Rad Laboratories, Inc.
BIO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,844 | -$637 | -$3,628 | $4,254 |
| Dep. & Amort. | $152 | $146 | $137 | $138 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $62 | $61 | $61 | $51 |
| Change in WC | -$621 | -$433 | -$1,610 | $1,143 |
| Other Non-Cash | $2,706 | $1,238 | $5,234 | -$4,917 |
| Operating Cash Flow | $455 | $375 | $194 | $669 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$166 | -$157 | -$113 | -$134 |
| Net Acquisitions | $0 | $3 | -$99 | -$126 |
| Inv. Purchases | -$1,277 | -$689 | -$2,060 | -$852 |
| Inv. Sales/Matur. | $1,305 | $863 | $1,066 | $767 |
| Other Inv. Act. | -$23 | $0 | -$1 | -$453 |
| Investing Cash Flow | -$160 | $20 | -$1,208 | -$797 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | $1,186 | -$3 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$204 | -$429 | -$216 | -$50 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$15 | $4 | $4 | -$2 |
| Financing Cash Flow | -$219 | -$426 | $974 | -$55 |
| Forex Effect | $9 | $0 | $3 | -$13 |
| Net Chg. in Cash | $85 | -$30 | -$37 | -$196 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $404 | $435 | $471 | $667 |
| End Cash | $490 | $404 | $435 | $471 |
| Free Cash Flow | $266 | $218 | $80 | $536 |